Downregulation of RBMS3 is associated with poor prognosis in esophageal squamous cell carcinoma

Cancer Research

Volumn 71, Issue 19, 2011, Pages 6106-6115

  Li, Yan ^a   Chen, Leilei ^b   Nie, Chang Jun ^a   Zeng, Ting Ting ^a   Liu, Haibo ^a   Mao, Xueying ^a   Qin, Yanru ^c   Zhu, Ying Hui ^a   Fu, Li ^b   Guan, Xin Yuan ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; MESSENGER RNA; MYC PROTEIN; PROTEIN RBMS3; RETINOBLASTOMA PROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGUS CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RBMS3 GENE; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 4; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MYC; RNA-BINDING PROTEINS; TRANS-ACTIVATORS;

EID: 80053349237     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-4291     Document Type: Article

References (28)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37 Suppl 8:S4-66.
2. Wei WQ, Yang J, Zhang SW, Chen WQ, Qiao YL. [Analysis of the esophageal cancer mortality in 2004-2005 and its trends during last 30 years in China]. Zhonghua Yu Fang Yi Xue Za Zhi 2010;44:398-402.
3. Carter CL, Hu N, Wu M, Lin PZ, Murigande C, Bonney GE. Segregation analysis of esophageal cancer in 221 high-risk Chinese families. J Natl Cancer Inst 1992;84:771-6.
4. Hu N, Dawsey SM, Wu M, Bonney GE, He LJ, Han XY, et al. Familial aggregation of oesophageal cancer in Yangcheng County, Shanxi Province, China. Int J Epidemiol 1992;21:877-82. (Pubitemid 23366729)
5. Hu N, Wang C, Ng D, Clifford R, Yang HH, Tang ZZ, et al. Genomic characterization of esophageal squamous cell carcinoma from a highrisk population in China. Cancer Res 2009;69:5908-17.
6. Kwong D, Lam A, Guan X, Law S, Tai A, Wong J, et al. Chromosomal aberrations in esophageal squamous cell carcinoma among Chinese: gain of 12p predicts poor prognosis after surgery. Hum Pathol 2004;35:309-16.
7. Ogasawara S, Maesawa C, Tamura G, Satodate R. Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 1995;55:891-4.
8. Yen CC, Chen YJ, Chen JT, Hsia JY, Chen PM, Liu JH, et al. Comparative genomic hybridization of esophageal squamous cell carcinoma: correlations between chromosomal aberrations and disease progression/prognosis. Cancer 2001;92:2769-77.
9. Qin YR, Fu L, Sham PC, Kwong DL, Zhu CL, Chu KK, et al. Singlenucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma. Int J Cancer 2008;123:826-30. (Pubitemid 352032408)
10. Fu L, Qin YR, Xie D, Hu L, Kwong DL, Srivastava G, et al. Characterization of a novel tumor-suppressor gene PLC delta 1 at 3p22 in esophageal squamous cell carcinoma. Cancer Res 2007;67:10720-6. (Pubitemid 350145898)
11. Zhu C, Qin YR, Xie D, Chua DT, Fung JM, Chen L, et al. Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma. Oncogene 2009;28:2821-8.
12. Penkov D, Ni R, Else C, Pinol-Roma S, Ramirez F, Tanaka S. Cloning of a human gene closely related to the genes coding for the c-myc single-strand binding proteins. Gene 2000;243:27-36. (Pubitemid 30079702)
13. Kimura K, Saga H, Hayashi K, Obata H, Chimori Y, Ariga H, et al. c- Myc gene single-strand binding protein-1, MSSP-1, suppresses transcription of alpha-smooth muscle actin gene in chicken visceral smooth muscle cells. Nucleic Acids Res 1998;26:2420-5. (Pubitemid 28297344)
14. Niki T, Izumi S, Saëgusa Y, Taira T, Takai T, Iguchi-Ariga SM, et al. MSSP promotes ras/myc cooperative cell transforming activity by binding to c-Myc. Genes Cells 2000;5:127-41. (Pubitemid 30120297)
15. Fritz D, Stefanovic B. RNA-binding protein RBMS3 is expressed in activated hepatic stellate cells and liver fibrosis and increases expression of transcription factor Prx1. J Mol Biol 2007;371: 585-95. (Pubitemid 47087833)
16. Shimada Y, Imamura M. Prognostic significance of cell culture in carcinoma of the oesophagus. Br J Surg 1993;80:605-7. (Pubitemid 23167241)
17. Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T. Characterization of 21 newly established esophageal cancer cell lines. Cancer 1992;69:277-84.
18. Wong ML, Tao Q, Fu L, Wong KY, Qiu GH, Law FB, et al. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma. Int J Oncol 2006;28:767-73.
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-8. (Pubitemid 34164012)
20. Wang Y, Wu MC, Sham JS, Tai LS, Fang Y, Wu WQ, et al. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue, studied using a tissue microarray. J Pathol 2002;197:610-6.
21. Li Y, Nie CJ, Hu L, Qin Y, Liu HB, Zeng TT, et al. Characterization of a novel mechanism of genomic instability involving the SEI1/SET/NM23H1 pathway in esophageal cancers. Cancer Res 2010;70:5695-705.
22. Negishi Y, Iguchi-Ariga SM, Ariga H. Protein complexes bearing myclike antigenicity recognize two distinct DNA sequences. Oncogene 1992;7:543-8.
23. Chen L, Chan TH, Yuan YF, Hu L, Huang J, Ma S, et al. CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients. J Clin Invest 2010;120:1178-91.
24. Niki T, Galli I, Ariga H, Iguchi-Ariga SM. MSSP, a protein binding to an origin of replication in the c-myc gene, interacts with a catalytic subunit of DNA polymerase alpha and stimulates its polymerase activity. FEBS Lett 2000;475:209-12. (Pubitemid 30408455)
25. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999;13:1501-12. (Pubitemid 29297917)
26. Beier R, Bürgin A, Kiermaier A, Fero M, Karsunky H, Saffrich R, et al. Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events. EMBO J 2000;19:5813-23.
27. Coqueret O. Linking cyclins to transcriptional control. Gene 2002;299: 35-55. (Pubitemid 35379826)
28. Paternot S, Bockstaele L, Bisteau X, Kooken H, Coulonval K, Roger PP. Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase. Cell Cycle 2010;9:689-99.